Discriminative stimulus properties of l-5-hydroxytryptophan: Behavioral evidence for multiple serotonin receptors-Reference-Cited by-同舟云学术

Discriminative stimulus properties of l-5-hydroxytryptophan: Behavioral evidence for multiple serotonin receptors

Published:1982-01 Issue:1 Volume:76 Page:29-35
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Barrett Robert J.,Blackshear M. Ann,Sanders-Bush Elaine

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF00430750.pdf

Reference34 articles.

1. Aprison MH, Ferster CB (1960) Behavioral effects of 5-hydroxytryptophan. Experientia 16:159?162

2. Aprison MH, Ferster CB (1961) Neurochemical correlates of behavior. I. Quantitative measurement of the behavioral effects of the serotonin precursor. J Pharmacol Exp Ther 131:100?107

3. Bedard P, Pycock CJ (1977) Wet-dog shake behavior in the rat: A possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology 16:663?670

4. Browne RG (1978) The role of serotonin in the discriminative stimulus properties of mescaline. In: Ho BT, Richards DN, Chute DL (eds) Drug discrimination and state-dependent learning. Academic Press, New York, pp 79?101

5. Browne RG, Ho BT (1975) Discriminative stimulus properties of mescaline: Mescaline or metabolite? Pharmacol Biochem Behav 3:109?114

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication;Life Sciences;1995-06

2. Development of Antidepressant Drugs;Neurochemistry in Clinical Application;1995

3. Drug discrimination using a Pavlovian conditional discrimination paradigm in pigeons;Pharmacology Biochemistry and Behavior;1994-12

4. Monoamine systems in the discriminative effects of spiradoline, a kappa-opioid agonist;Pharmacology Biochemistry and Behavior;1994-03

5. Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcement;Psychopharmacology;1994-01